ANGPT2 and hepatocellular carcinoma: The current study shows that ANG-2 is also associated with decreased UM-related survival, which is in line with previous studies in which the role of angiopoietins has been investigated in other types of cancer, especially in hepatocellular carcinoma and lung cancer [30,34,35,36].